The JAK1/STAT3/SOCS3 axis in bone development, physiology, and pathology
Open Access
- 13 August 2020
- journal article
- review article
- Published by Springer Science and Business Media LLC in Experimental & Molecular Medicine
- Vol. 52 (8), 1185-1197
- https://doi.org/10.1038/s12276-020-0445-6
Abstract
Bone growth and the maintenance of bone structure are controlled by multiple endocrine and paracrine factors, including cytokines expressed locally within the bone microenvironment and those that are elevated, both locally and systemically, under inflammatory conditions. This review focuses on those bone-active cytokines that initiate JAK–STAT signaling, and outlines the discoveries made from studying skeletal defects caused by induced or spontaneous modifications in this pathway. Specifically, this review describes defects in JAK1, STAT3, and SOCS3 signaling in mouse models and in humans, including mutations designed to modify these pathways downstream of the gp130 coreceptor. It is shown that osteoclast formation is generally stimulated indirectly by these pathways through JAK1 and STAT3 actions in inflammatory and other accessory cells, including osteoblasts. In addition, in bone remodeling, osteoblast differentiation is increased secondary to stimulated osteoclast formation through an IL-6-dependent pathway. In growth plate chondrocytes, STAT3 signaling promotes the normal differentiation process that leads to bone lengthening. Within the osteoblast lineage, STAT3 signaling promotes bone formation in normal physiology and in response to mechanical loading through direct signaling in osteocytes. This activity, particularly that of the IL-6/gp130 family of cytokines, must be suppressed by SOCS3 for the normal formation of cortical bone.Keywords
Funding Information
- Department of Health | National Health and Medical Research Council (1154819, 1120978)
This publication has 92 references indexed in Scilit:
- An update on the hyper-IgE syndromesArthritis Research & Therapy, 2012
- Zinc Finger Protein 467 Is a Novel Regulator of Osteoblast and Adipocyte CommitmentOnline Journal of Public Health Informatics, 2011
- Gene expression patterns in bone following mechanical loadingJournal of Bone and Mineral Research, 2010
- Oncostatin M promotes bone formation independently of resorption when signaling through leukemia inhibitory factor receptor in miceJCI Insight, 2010
- A critical role for interleukin-6 family-mediated Stat3 activation in osteoblast differentiation and bone formationBone, 2006
- SOCS-3 negatively regulates innate and adaptive immune mechanisms in acute IL-1-dependent inflammatory arthritisJCI Insight, 2006
- Osteoporosis with increased osteoclastogenesis in hematopoietic cell-specific STAT3-deficient miceBiochemical and Biophysical Research Communications, 2005
- Essential Role of STAT3 in Postnatal Survival and Growth Revealed by Mice Lacking STAT3 Serine 727 PhosphorylationMolecular and Cellular Biology, 2004
- Activated T Lymphocytes Support Osteoclast Formation in VitroBiochemical and Biophysical Research Communications, 1999
- Cytokine-Mediated Bone Resorption in Patients with the Hyperimmunoglobulin E SyndromeClinical Immunology and Immunopathology, 1995